Literature DB >> 10086981

Response surface analysis of synergism between morphine and clonidine.

R J Tallarida1, D J Stone, J D McCary, R B Raffa.   

Abstract

Graded doses of morphine sulfate and clonidine hydrochloride were administered intrathecally to mice that were then tested for antinociception in the 55 degrees C tail immersion test. The dose-effect relations of each compound were used in calculations that permitted the construction of a three-dimensional plot of the expected additive effect (vertical scale) against the planar domain of dose pairs representing combinations administered simultaneously. This additive response surface became the reference surface for viewing the actual effects produced by three different fixed-ratio combinations of the drugs that were used in our tests. Each combination produced effects significantly greater than indicated by the additive surface, thereby illustrating marked synergism and a method for quantifying the synergism. This quantification, measured by the value of the interaction index (alpha), was found to be dependent on the fixed-ratio combination; accordingly, the actual response surface could not be described by a single value of the index alpha. Furthermore, we found that application of the common method of isoboles gave estimates of the index that agreed well with those obtained from the more extensive surface analysis. These results confirm earlier studies, which found synergism for these drugs while also providing surface views of additivity and synergism that form the basis of isobolographic analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086981

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Commentary on neostigmine interactions with non steroidal anti-inflammatory drugs by Miranda et al.

Authors:  Ronald J Tallarida
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 2.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

3.  Quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  Genes Cancer       Date:  2011-11

4.  Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-14       Impact factor: 3.000

Review 5.  The determination and application of fixed-dose analgesic combinations for treating multimodal pain.

Authors:  Robert B Raffa; Joseph V Pergolizzi; Ronald J Tallarida
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

Review 6.  A systematic review of pharmacologic treatments of pain after spinal cord injury.

Authors:  Robert W Teasell; Swati Mehta; Jo-Anne L Aubut; Brianne Foulon; Dalton L Wolfe; Jane T C Hsieh; Andrea F Townson; Christine Short
Journal:  Arch Phys Med Rehabil       Date:  2010-05       Impact factor: 3.966

7.  Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.

Authors:  Frederik Rode; Tine Broløs; Gordon Blackburn-Munro; Ole J Bjerrum
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

8.  Three-dimensional isobolographic analysis of interactions between lamotrigine and clonazepam in maximal electroshock-induced seizures in mice.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-23       Impact factor: 3.000

9.  Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat.

Authors:  Andrew J Grottick; Kevin Whelan; Erin K Sanabria; Dominic P Behan; Michael Morgan; Carleton Sage
Journal:  Psychopharmacology (Berl)       Date:  2014-12-20       Impact factor: 4.530

10.  Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.

Authors:  Simona Daniele; Barbara Costa; Elisa Zappelli; Eleonora Da Pozzo; Simona Sestito; Giulia Nesi; Pietro Campiglia; Luciana Marinelli; Ettore Novellino; Simona Rapposelli; Claudia Martini
Journal:  Sci Rep       Date:  2015-04-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.